Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$13.88
0.000.00%
After Hours: Dec 19, 4:00 PM EDT
Comments
Loading...
Inhibrx Biosciences (INBX) Forecast
NewsEarningsInhibrx Biosciences (INBX) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Inhibrx Biosciences (NASDAQ:INBX) Stock Quotes, Forecast and News Summary
Inhibrx Biosciences Stock (NASDAQ: INBX) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Inhibrx Biosciences (INBX) stock?
You can purchase shares of Inhibrx Biosciences (NASDAQ:INBX) through any online brokerage.
Who are Inhibrx Biosciences (INBX) competitors?
Other companies in Inhibrx Biosciences’s space includes: Macrogenics (NASDAQ:MGNX), Renovaro (NASDAQ:RENB), Precigen (NASDAQ:PGEN), Zentalis Pharma (NASDAQ:ZNTL) and Inozyme Pharma (NASDAQ:INZY).
What is the forecast, or price target, for Inhibrx Biosciences (INBX) stock?
Inhibrx Biosciences has a consensus price target of $45.25.
What is the current price for Inhibrx Biosciences (INBX)?
The stock price for Inhibrx Biosciences (NASDAQ: INBX) is $14.49 last updated December 20, 2024 at 3:58 PM EST.
Does Inhibrx Biosciences (INBX) pay a dividend?
There are no upcoming dividends for Inhibrx Biosciences.
When is Inhibrx Biosciences (NASDAQ:INBX) reporting earnings?
Inhibrx Biosciences’s Q3 earnings are confirmed for Thursday, November 14, 2024.
Is Inhibrx Biosciences (INBX) going to split?
There is no upcoming split for Inhibrx Biosciences.
What sector and industry does Inhibrx Biosciences (INBX) operate in?
Inhibrx Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.